Home » Stocks » Vermillion

Vermillion, Inc. (VRML)

Jun 12, 2020 - Stock symbol was changed to AWH
Stock Price: $4.00 USD 0.00 (0.00%)
Updated Jun 11, 2020 4:00 PM EDT

Stock Price Chart

Key Info

Market Cap 389.51M
Revenue (ttm) 4.96M
Net Income (ttm) -15.23M
Shares Out 100.19M
EPS (ttm) -0.17
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jun 11, 2020
Last Price $4.00
Previous Close $4.00
Change ($) 0.00
Change (%) 0.00%
Day's Open 3.93
Day's Range 4.00 - 4.75
Day's Volume 743,319
52-Week Range 0.35 - 5.78

More Stats

Market Cap 389.51M
Enterprise Value 382.62M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 100.19M
Float 52.24M
EPS (basic) -0.18
EPS (diluted) -0.17
FCF / Share -0.14
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 2.17M
Short Ratio 4.21
Short % of Float 4.63%
Beta 3.47
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 78.61
PB Ratio 87.11
Revenue 4.96M
Operating Income -15.36M
Net Income -15.23M
Free Cash Flow -13.47M
Net Cash 6.89M
Net Cash / Share 0.07
Gross Margin 24.12%
Operating Margin -309.97%
Profit Margin -307.30%
FCF Margin -271.77%
ROA -103.18%
ROE -340.69%
ROIC 3,863.20%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0
What these ratings mean

Analyst Consensus: n/a

Price Target

$1.00*
Low
1.00
Current: $4.00
High
1.00
Target: 1.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Income Statement | Balance Sheet | Cash Flow
Year2019201820172016201520142013201220112010
Revenue4.543.053.122.642.182.522.572.091.921.18
Revenue Growth48.64%-2.18%18.13%21.36%-13.65%-1.75%22.54%8.89%63.66%-
Gross Profit1.20-0.090.21-0.06-0.131.292.401.961.791.09
Operating Income-15.28-11.33-10.44-14.95-19.25-19.21-8.86-8.62-17.74-16.28
Net Income-15.24-11.37-10.50-14.97-19.12-19.21-8.82-7.15-17.79-19.03
Shares Outstanding86.6070.0956.9452.2047.1236.0820.9315.0114.2510.40
Earnings Per Share-0.18-0.16-0.20-0.29-0.41-0.53-0.42-0.48-1.25-1.83
Operating Cash Flow-12.97-9.37-8.13-13.96-18.37-16.81-8.22-10.40-15.58-20.94
Capital Expenditures-0.13-0.11-0.06-1.26-1.06-0.26-0.32-0.01-0.10-0.18
Free Cash Flow-13.10-9.48-8.19-15.22-19.42-17.07-8.55-10.41-15.68-21.11
Cash & Equivalents11.709.365.545.2418.6422.9729.508.0122.4822.91
Total Debt1.291.481.671.85-1.111.111.117.0012.00
Net Cash / Debt10.417.883.873.3918.6421.8628.406.9015.4810.91
Assets13.8311.417.508.0220.9624.1730.648.6323.1124.04
Liabilities5.094.264.094.263.414.923.873.9712.7519.42
Book Value8.747.153.413.7617.5519.2626.774.6710.364.62
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Vermillion, Inc.
Country United States
Employees 52
CEO Valerie Barber Palmieri

Stock Information

Ticker Symbol VRML
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: VRML
IPO Date September 29, 2000

Description

Vermillion, Inc., together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance gynecologic health outcomes for women in the United States. The company's diagnostic tests include OVA1, a blood test for the pre-surgical identification of women who are at high risk of having a malignant ovarian tumor; and Overa, a multivariate index assay second generation test to determine the malignancy of ovarian cancer in women. It also offers in-vitro diagnostic (IVD) trial services to third-party customers; and laboratory services to meet the needs of IVD manufacturers to commercialize high-complexity assays. The company serves clinical reference laboratories, hospital laboratories, and physician offices. Vermillion, Inc. was founded in 1993 and is headquartered in Austin, Texas.